Intraoperative post-annuloplasty three-dimensional valve analysis does not predict recurrent ischemic mitral regurgitation

Table 1 Preoperative and intraoperative patient characteristics

Variable^a	Normal	Non-recurrent	Recurrent
Variable^a	(n = 21)	IMR (n = 26)	IMR (n = 9)
Age, years	66.1 ± 14.4	67.5 ± 9.7	65.9 ± 6.0
Female	8 (38)	8 (31)	3 (33)
Body mass index, kg/m²	32.2 ± 8.0	28.4 ± 4.3	28.2 ± 4.2
Medical history
Hypertension	11 (52)	19 (73)	7 (78)
Diabetes	6 (29)	12 (46)	4 (44)
Renal insufficiency	3 (14)	6 (23)	1 (11)
Atrial fibrillation	2 (10)	11 (42)	3 (33)
Stroke	2 (10)	2 (8)	1 (11)
Previous PCI	3 (14)	7 (27)	4 (44)
Previous CABG	2 (10)	3 (12)	4 (44)
NYHA class, 1-4 scale	2.4 ± 0.8	2.3 ± 1.0	2.8 ± 0.4
IMR grade, 0-4 scale	0.3 ± 0.5	3.0 ± 0.7^c	3.0 ± 0.8^d
Inferior wall motion abnormality	0 (0)	23 (88)	9 (100)
Left ventricular
End-diastolic diameter, cm	4.7 ± 0.8	5.7 ± 0.9^c	6.1 ± 0.9^d
End-systolic diameter, cm	3.2 ± 0.8	4.6 ± 1.0^c	5.1 ± 1.4^d
Ejection fraction, %	65.2 ± 10.1	36.0 ± 15.7^c	31.9 ± 11.6^d
Annuloplasty ring
Profile 3D ring^e	−	12 (46)	8 (89)
CE Physio II ring^f	−	7 (27)	1 (11)
CG Future band^e	−	6 (23)	0 (0)
St. Jude tailor flexible ring^g	−	1 (4)	0 (0)
Ring size, mm	−	28.9 ± 1.7	28.7 ± 1.4
Concomitant procedures
CABG	6 (29)	20 (77)^c	6 (67)
Aortic valve replacement	14 (67)	2 (8)^c	0 (0)^d
Tricuspid valve repair	0 (0)	1 (4)	1 (11)
Atrial maze	0 (0)	5 (19)	0 (0)
Atrial septal defect closure	1 (5)	0 (0)	0 (0)

3D three-dimensional, CABG coronary artery bypass grafting, IMR ischemic mitral regurgitation, NYHA New York Heart Association, PCI percutaneous coronary intervention
^aData are presented as mean±standard deviation or number (%)
^bP < 0.05 recurrent vs non-recurrent
^cP < 0.05 non-recurrent vs normal
^dP < 0.05 recurrent vs normal
^eMedtronic, Minneapolis, MN
^fCarpentier-Edwards, Irvine, CA
^gSt. Jude Medical, St. Paul, MN

ISSN: 1749-8090